The outbreak of the global pandemic has increased the hesitation of patients undergoing their treatments during such critical times. While their apprehension seems to overpower, doctors need to ensure to follow strict guidelines and protocols which assure the best quality service. Furthermore, delays in medical assistance, surgeries, or even transplantations can lead to severe repercussions.
That said, of elective surgeries, transplants, and other treatments, a bone marrow transplant is one of many that has seen a rise in the past few months. While bone marrow or stem transplant cases have increased substantially, adhering to guidelines for pre-transplant evaluation and the management of a common complication, graft versus host disease (GVHD), is essential. With the diversity of practice and expertise, following guidelines will provide a pivotal tool for learning about the rapidly updated therapy landscape in Hematopoietic stem cell transplantation (HSCT).
The guidelines intended to provide a systematic approach for transplantation and help streamline clinical practices and educate new generations of physicians-in-training. Additionally, guidelines help evaluate a potential transplant recipient to determine if the patient is an eligible candidate for the procedure.
Selection of the type of transplantation for a patient depends on factors such as the type of malignancy, availability of a suitable donor, age of the recipient, the ability to collect a tumor-free autograft, the stage, the malignancy's susceptibility to the GVM effect, and status of disease -- bone marrow involvement, the bulk of disease, chemosensitivity to conventional chemotherapy. This method is particularly applicable for Autologous or Allogeneic Transplantation where one can have a sibling donor or a matched unrelated donor. In the case of a matched unrelated donor, ensure that the collection is adequate and stem cells are available well in time especially if they are imported from countries like Europe.
A haploidentical transplant is another type of transplant that uses healthy, blood-forming cells from a half-matched donor to replace the unhealthy ones. The ideal donor in this case is a family member.
That said, for bone marrow transplant blood products are the backbone and it is important to ensure to have adequate supply before you begin with the transplant.
Some measures for consideration are:
● Minimize face to face visits including monitoring, and consider shifting to telehealth where feasible
● Some adaptive community measures like the hospital in the home services, community practices for blood collection, imaging and support services, etc.
● For radiation oncology treatment, consider reducing fractions when supported by evidence
● Consider alternative and less resource-intensive treatment regimes.
● Minimize unnecessary visitors to cancer centers, for instance, limiting to only patients and their essential caregivers based on frailty and language needs
● Screen for possible symptoms of COVID-19 and triage patients for admission. If necessary, the admission has to be directed to oncology/hematology departments rather than emergency departments.
● Immunocompromised patients are likely to have atypical presentations of COVID-19
● For suspected checkpoint inhibitor-related pneumonitis prioritizes COVID-19 testing for an early decision regarding corticosteroid therapy.
These are some guidelines that you should heed during a bone marrow transplant. While it is imperative to be updated about the guidelines, timely intervention can reduce the other possible complications during the process.
If you want to Question Cancer, you can write to us at email@example.com
With 28 hospitals across the nation and over 4000+ beds, Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. For over 26 years, Fortis Hospitals have been committed to the cause of getting people back to their lives faster and stronger.